Intrabio Inc Is A Biopharmaceutical Company Dedicated To Discovering And Developing New Therapies For Rare Neurodegenerative Diseases And Age Related Conditionsfounded In 2015 And Based In Oxfordshireukwith Operations In Austintexasintrabio Aims To Meet Significant Medical Needs Through Innovative Drug Development The Company Is Currently In The Clinical Stage And Has Raised Over $50 Million In Fundingincluding A Recent $40 27 Million Roundits Lead Investigational Drugib1001Is An Orally Administered Modified Amino Acid Designed To Improve Metabolic Function In Neurodegenerative Diseasesintrabio Conducts Clinical Trials For Conditions Such As Gm2 Gangliosidosis And Ataxia Telangiectasiawith A Focus On Enhancing The Quality Of Life For Patients And Their Caregiversthe Company Holds 19 Patents Related To Rare Diseases And Maintains A Global Presence With Clinical Trials Involving International Cohorts
No conferences found for this company.
| Company Name | Intrabio Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
